MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,718 | -88.5% | 5,595 | -90.5% | 0.00% | -100.0% |
| Q2 2023 | $2,117,106 | -11.4% | 58,597 | -8.8% | 0.00% | -20.0% |
| Q1 2023 | $2,389,705 | -12.1% | 64,274 | +7.1% | 0.01% | -16.7% |
| Q4 2022 | $2,719,777 | +45.2% | 60,026 | +123.6% | 0.01% | +50.0% |
| Q3 2022 | $1,873,000 | +15.8% | 26,840 | +11.2% | 0.00% | +33.3% |
| Q2 2022 | $1,618,000 | -66.2% | 24,139 | -58.6% | 0.00% | -62.5% |
| Q1 2022 | $4,789,000 | -32.5% | 58,254 | +20.3% | 0.01% | -27.3% |
| Q4 2021 | $7,099,000 | +3.7% | 48,406 | +25.0% | 0.01% | -8.3% |
| Q3 2021 | $6,849,000 | +26.5% | 38,726 | +15.5% | 0.01% | +33.3% |
| Q2 2021 | $5,416,000 | +144.3% | 33,536 | +159.0% | 0.01% | +125.0% |
| Q1 2021 | $2,217,000 | -75.3% | 12,947 | -68.3% | 0.00% | -77.8% |
| Q4 2020 | $8,971,000 | +53.9% | 40,860 | +16.4% | 0.02% | +38.5% |
| Q3 2020 | $5,829,000 | +145.8% | 35,114 | +69.0% | 0.01% | +160.0% |
| Q2 2020 | $2,371,000 | +24.5% | 20,776 | -16.1% | 0.01% | 0.0% |
| Q1 2020 | $1,905,000 | -49.5% | 24,758 | -15.4% | 0.01% | -28.6% |
| Q4 2019 | $3,771,000 | +116.1% | 29,282 | +31.0% | 0.01% | +133.3% |
| Q3 2019 | $1,745,000 | -24.8% | 22,345 | -0.8% | 0.00% | -25.0% |
| Q2 2019 | $2,322,000 | +40.8% | 22,530 | +0.2% | 0.00% | +33.3% |
| Q1 2019 | $1,649,000 | +2694.9% | 22,494 | +98.9% | 0.00% | – |
| Q1 2017 | $59,000 | – | 11,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |